BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-25 out of over 1000 found
  Current Search:  vaccin: 5959     

HTML
100%
Dynavax Enters Into Supply and Option Agreement for Development of Universal Influenza Vaccine
Novartis Will Contribute Trivalent Vaccine to the Collaboration BERKELEY, Calif.--(BUSINESS WIRE)--Dynavax Technologies Corporation (Nasdaq:DVAX - News) today announced an agreement with Novartis Vaccines and Diagnostics, Inc.
Business Wire via Yahoo!:  Jul 23 2008 10:49PM
Matching: vaccin
Find similar documents
HTML
100%
Emergent BioSolutions Awarded Two Grants from NIAID to Support Development of the Company's Recombinant Botuli
The rBOT Grant is the First Government Award in Support of the Company's Botulinum Vaccine Program ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc.

(NYSE:EBS - News) announced today that it has secured two grants totaling...

Yahoo!:  Jul 24 2008 4:11AM
Matching: vaccin
Find similar documents
HTML
100%
Emergent BioSolutions Awarded Two Grants from NIAID to Support Development of the Company's Recombinant Botuli
Emergent BioSolutions Inc.

(NYSE:EBS) announced today that it has secured two grants totaling over $4.5 million from The National Institute of Allergy and Infectious Diseases (NIAID) to fund the continued development of the company's rBOT...

Genetic Engineering News:  Jul 24 2008 5:44AM
Matching: vaccin
Find similar documents
HTML
100%
Fallout From Failed AIDS Vaccine Could Dampen Research
Experts worry infection fears might keep participants from trials HealthDay Reporter MONDAY, Nov.

12 (HealthDay News) -- An experimental AIDS vaccine used in a recent trial may have placed participants at higher risk of infection...

Dental Plans:  Jul 24 2008 12:22PM
Matching: vaccin
Find similar documents
HTML
100%
Emergent BioSolutions and the University of Oxford Form Joint Venture to Develop an Advanced Tuberculosis Vacc
- The University of Oxford and Emergent BioSolutions Inc.

(NYSE:EBS) announced today that they have formed a joint venture, The Oxford-Emergent Tuberculosis Consortium Ltd.

(the 'Consortium'), to further develop MVA85A, the world's most...

Pharma Live:  Jul 23 2008 10:56PM
Matching: vaccin
Find similar documents
HTML
100%
As Parents Nix Vaccine, Childhood Whooping Cough Increases
Incidence highest in states with loosest exemption policies, study finds HealthDay Reporter TUESDAY, Oct.

10 (HealthDay News) -- More parents are refusing to have their children immunized against common childhood diseases, as some states...

Dental Plans:  Jul 24 2008 12:58PM
Matching: vaccin
Find similar documents
HTML
100%
USCIS Tightens Vaccination Requirements
Full line of vaccines for Immigration and Naturalization ready at Passport Health BALTIMORE, July 23, 2008 /PRNewswire/ -- New vaccine requirements will affect anyone who is applying for an immigrant visa for entry into the U.S....
Pharmalive.com:  Jul 24 2008 2:22AM
Matching: vaccin
Find similar documents
HTML
100%
Emergent BioSolutions and University of Oxford join hands to develop TB vaccine
The University of Oxford, through its technology transfer office, Isis Innovation, has exclusively licensed the MVA85A tuberculosis (TB) vaccine candidate and related technology to the consortium.

The consortium will work with the...

Pharmaceutical Business Review:  Jul 24 2008 4:10AM
Matching: vaccin
Find similar documents
HTML
100%
New Research Finds Live Influenza Vaccine Is Just as Safe for HIV-Infected Children; Current Recommendation Ha
AURORA, Colo., July 22 (AScribe Newswire) -- Between September and mid-November in 2004, 243 HIV-infected children ages 5 to 18 years, who were receiving antiretroviral therapy for their condition, were randomly assigned to receive either...
Ascribe:  Jul 24 2008 12:43PM
Matching: vaccin
Find similar documents
HTML
100%
HPV vaccine to help fight cervical cancer
In an effort to fast-track the spread of cervical cancer, the Ministry of Health recently introduced the HPV vaccine.

Now available in the local market, the vaccine can be used by females within the age bracket of 9-26 years.

The Monitor:  Jul 24 2008 12:48AM
Matching: vaccin
Find similar documents
HTML
100%
Revised Vaccination Recommendations for Upcoming Flu Season
The Centers for Disease Control and Preventions Advisory Committee on Immunization Practices (ACIP) has new and updated recommendations for the use of influenza vaccine and antiviral agents for the upcoming 2008-2009 flu season.

The...

Facts & Comparisons:  Jul 24 2008 12:51PM
Matching: vaccin
Find similar documents
HTML
100%
Dr. Gott: Difficulty finding shingles vaccine
Dear Dr.

Gott: I was able to convince my mother to get the shingles vaccine, but her doctor wouldnt administer it because of the short window in which it has to be given.

Mom and I searched for weeks to find a healthcare provider...

Northwest Herald:  Jul 24 2008 4:46AM
Matching: vaccin
Find similar documents
HTML
100%
Family Doctor: Problem finding shingles vaccine
ultimedia Sports Videos Lifestyle Headlines Singles events Looking back Your life EngagementsRecent Headlines Cooking classes Bridal Information Special Forms Anniversary Form Engagement Form Wedding Form Q: I was finally able to convince my...
Canton Repository:  Jul 24 2008 11:37AM
Matching: vaccin
Find similar documents
HTML
100%
Shingles vaccination can be an arduous journey
Dear Dr.

Gott: After reading your column about Zostavax, I had to write.

I was finally able to convince my mother to get the shingles vaccine, but her doctor would only give her a prescription for it.

He wouldn't administer it...

Tulsa World:  Jul 24 2008 7:30AM
Matching: vaccin
Find similar documents
HTML
100%
Dynavax inks flu vaccine deal with Novartis
San Francisco Business Times - by Steven E.F.

Brown Related News Dynavax to drop allergy program that failed test [East Bay] Bio pioneer takes new approach [San Francisco] Boost from Merck cuts Dynavax Technologies' Q1 loss [San Francisco]...

Philadelphia Business Journal:  Jul 23 2008 11:53PM
Matching: vaccin
Find similar documents
HTML
100%
GeoVax Enters HIV/AIDS Vaccine Manufacturing Partnership
GeoVax Partners with Vivalis for Use of Its Revolutionary EBx Technology to Manufacture Its MVA HIV/AIDS Vaccine Tuesday July 22, 1:30 am ET - Partnership creates worldwide strategic collaboration between Vivalis and GeoVax ATLANTA and...
Pharma Live:  Jul 23 2008 12:36PM
Matching: vaccin
Find similar documents
HTML
100%
GeoVax Partners with Vivalis for Use of Its Revolutionary EBx Technology to Manufacture Its MVA HIV/AIDS Vacci
Partnership creates worldwide strategic collaboration between Vivalis and GeoVax ATLANTA and NANTES, France, July 22, 2008 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc.

, an Atlanta based, biopharmaceutical company developing human ...

Pharmalive.com:  Jul 23 2008 1:13AM
Matching: vaccin
Find similar documents
HTML
100%
GeoVax Partners With Vivalis For Use Of Its Revolutionary Ebx® Technology To Manufacture Its MVA HIV/AIDS
GeoVax Labs, Inc., an Atlanta based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, together with Vivalis, a French biopharmaceutical company...
Pharmaceutical Online:  Jul 23 2008 12:50PM
Matching: vaccin
Find similar documents
HTML
100%
Emergent BioSolutions and the University of Oxford form joint venture to develop an advanced Tuberculosis vacc
Wellcome Trust and Aeras Global TB Vaccine Foundation have agreed to provide GBP 8 million in funding for Phase IIb clinical trial that is expected to commence in 2009 -- The vaccine candidate, MVA85A, has been granted orphan...
Checkbiotech:  Jul 23 2008 1:57PM
Matching: vaccin
Find similar documents
HTML
100%
Emergent BioSolutions and the University of Oxford Form Joint Venture to Develop an Advanced Tuberculosis Vacc
-- Wellcome Trust and Aeras Global TB Vaccine Foundation have agreed to provide GBP 8 million in funding for Phase IIb clinical trial that is expected to commence in 2009 -- The vaccine candidate, MVA85A, has been granted orphan...
Yahoo!:  Jul 23 2008 4:19AM
Matching: vaccin
Find similar documents
HTML
100%
Emergent BioSolutions and the University of Oxford Form Joint Venture to Develop an Advanced Tuberculosis Vacc
- The University of Oxford and Emergent BioSolutions Inc.

(NYSE:EBS) announced today that they have formed a joint venture, The Oxford-Emergent Tuberculosis Consortium Ltd.

(the 'Consortium'), to further develop MVA85A, the world's most...

Pharmalive.com:  Jul 23 2008 1:16PM
Matching: vaccin
Find similar documents
HTML
100%
Emergent BioSolutions and the University of Oxford Form Joint Venture to Develop an Advanced Tuberculosis Vacc
The University of Oxford and Emergent BioSolutions Inc.

(NYSE:EBS) announced today that they have formed a joint venture, The Oxford-Emergent Tuberculosis Consortium Ltd.

(the 'Consortium'), to further develop MVA85A, the world's most...

Genetic Engineering News:  Jul 23 2008 4:38AM
Matching: vaccin
Find similar documents
HTML
100%
Dynavax Enters Into Supply and Option Agreement for Development of Universal Influenza Vaccine
Novartis Will Contribute Trivalent Vaccine to the Collaboration BERKELEY, Calif.--(BUSINESS WIRE)--Dynavax Technologies Corporation (Nasdaq:DVAX) today announced an agreement with Novartis Vaccines and Diagnostics, Inc.

for the...

Business Wire:  Jul 23 2008 8:56PM
Matching: vaccin
Find similar documents
HTML
100%
FDA Approvals: KINRIX and Metvixia
Describe the appropriate use of a new pediatric vaccine against diphtheria, tetanus, pertussis, and polio diseases.

Describe the potential benefits of methyl aminolevulinate cream plus photodynamic therapy for the treatment of...

Medscape:  Jul 23 2008 8:34PM
Matching: vaccin
Find similar documents
HTML
100%
Vaccine Executive Staph Bakali Joins Genocea Biosciences' Board of Directors
Director at Intercell AG and Former COO of ID Biomedical brings 20 years of vaccine development and management expertise CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, a leading vaccine discovery and development company,...
Yahoo! Canada:  Jul 23 2008 1:23PM
Matching: vaccin
Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.